This site is intended for health professionals only!

Views
Remdesivir: the new wonder drug for COVID-19?
By Rod Tucker BPharm PhD
Excessive duration of antibiotic therapy in transition care: an opportunity for pharmacists?
By Hospital Pharmacy Europe
Repurposing indomethacin for COVID-19
By Christine Clark PhD FRPharmS FCPP(Hon)
Hospital pharmacist-led medicine optimisation clinics reduces re-admission rates
By Hospital Pharmacy Europe
Commentary: Higher incidence of adverse events with warfarin compared with apixaban in DVT
Commentary: High level of medication errors in UK fortunately not clinically important
Commentary: Rapid spread of viral DNA across surfaces in hospital wards cause for concern
Commentary: Addition of rituximab improves survival in children with B-cell lymphomas
Are anticoagulants protective against COVID-19?
View: Impact of the pandemic on hospital pharmacy in Europe
By Tiene Bauters PharmD PhD
Increased physical activity equals reduced cancer risk in older adults
Health outcomes in cardiovascular disease better for women than men


Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
User-friendly osteoporosis therapy launched
4
Merck agrees huge Vioxx settlement
5
Janssen-Cilag’s Stelara approved by NICE



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe